The Clinical Comparison of Antidiabetic Agents Treating Postprandial Hyperglycemia, between Repaglinide alone and Mitiglide/Voglibose Fixed-dose Combination using Continuous Glucose Monitoring on Postprandial Profiles.
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000025235
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have severe diabeticketosis, diabetic coma 2)Patients with severe infections, severe injury or perioperative state. 3)Female patients who have pregnancy or possibilty of pregnancy, or are under lactation 4)Patients who had past history of hypersensitivity or allergic reaction to insulin degludec, aspart or liraglutide 5)Patients with severe liver or renal dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method